Bone Cancer & Sarcoma in China
Overview
Bone cancer — primary sarcomas such as osteosarcoma and Ewing sarcoma, and metastases from other cancers — demands treatment at centers combining oncologic surgery, chemotherapy and reconstruction expertise.
Chinese musculoskeletal tumor centers treat large volumes with limb-salvage philosophy: neoadjuvant chemotherapy, wide resection and custom prosthetic reconstruction preserve the limb in the great majority of patients.
Symptoms & Signs
Persistent bone pain, often worse at night and unrelieved by rest
A palpable swelling or mass around a bone
Progressive limp or loss of limb function
Pathologic fracture after minor injury
Weight loss and fatigue in high-grade or metastatic disease
Known cancer elsewhere with new localized bone pain suggesting metastasis
Diagnosis
Plain radiographs and contrast MRI of the entire bone defining extent
CT of the chest staging pulmonary metastases
Bone scan or PET-CT surveying the skeleton
Image-guided core needle biopsy planned with the surgeon
Pathology review with molecular testing classifying the tumor
Laboratory markers including alkaline phosphatase and LDH
Treatment Options
Neoadjuvant chemotherapy for osteosarcoma and Ewing sarcoma
Wide en-bloc resection with limb salvage
Custom or modular endoprosthetic reconstruction
Biologic reconstruction with allograft or bone transport in selected patients
Bone-targeted agents (bisphosphonate-class, anti-RANKL) for metastatic bone disease
Radiotherapy for radiosensitive tumors and metastases
Advanced Technologies & Novel Drug
3D-printed custom prostheses matching patient anatomy
Navigation-assisted resection with margin control
Computer-navigated implant placement
Intraoperative pathology confirming margins
Novel targeted agents for refractory sarcoma subtypes
Hospital & Specialist
- Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS) — Beijing
- Shanghai Sixth People's Hospital — Shanghai
- Sun Yat-sen University Cancer Center (SYSUCC) — Guangzhou
- Fudan University Shanghai Cancer Center (FUSCC) — Shanghai
- Yang Yun — Bone & Soft Tissue Tumor
- Fan Zheng Fu — Bone & Soft Tissue Tumor
- Wang Guo Wen — Bone & Soft Tissue Tumor
- Liu Jia Yong — Bone & Soft Tissue Tumor